Life Science Instrumentation Market

Market Insights

The life science instrumentation market is expected to reach US$ 100,792.7 million by 2027, up from US$ 57,185.5 million in 2018, with a compounded annual growth rate (CAGR) of 6.5% from 2019 to 2027. Technological advancements in life science instruments, as well as stringent healthcare standards governing food and drug manufacturing processes, are driving the market growth for life science instrumentation techniques.

Rising public health awareness and proactive government policies to curb the mortality associated with chronic diseases further propel the demand for life science instrumentation technology in the pharmaceutical and biotechnology industries.

Market Synopsis

In the life science industry, spectroscopy technology is in high demand due to the lack of sample preparation for analysis and its broad applicability during the quality control of end products.

Spectroscopy is a very old and reliable technology that is very popular among researchers working in the life science industry. It currently holds the largest market in the technology segment of the life science instrumentation market. Ease of handling, lack of sample preparation, and wide utilization during quality control of end products across the life science industry drive the spectroscopy technology market’s growth.

Next-generation sequencing is set to capture the market in the near future on account of its ease of creating biological sequences for complex samples at low cost and speed and its wide application in the development of personalized medicine.

Burgeoning requirements for novel drugs and stringent norms stipulated by healthcare agencies worldwide drive the pharmaceutical and biotechnology companies’ markets.

Pharmaceutical and biotechnology companies are the largest revenue holders in the life science instrumentation market’s end-user segment. Stringent guidelines stipulated by healthcare agencies worldwide pertaining to cGMP and GLP during drug discovery and development drive market growth for pharmaceutical and biotechnology companies.

Burgeoning requirements for novel drugs to treat chronic diseases further propel the demand for life science instrumentation technology in the pharmaceutical and biotechnology industries.

Diagnostic laboratories will register the fastest growth in the near future owing to rising public health awareness resulting in early disease diagnosis and the availability of a skilled labor force to perform precise and accurate screening and interpretation of analytical and biological samples.

The existence of well-developed pharmaceutical and biotechnology companies and flourishing research activities drive market growth in North America.

North America is presently leading the regional segment of the life science instrumentation market, holding 32% of the market. The drivers associated with its market growth are the existence of well-developed pharmaceutical and biotechnology companies and flourishing research activities.

A significant rise in the number of patients suffering from lifestyle disorders triggers the need for the development of safe and efficacious drugs for treatment in the region. Europe is in the second position, representing 30% of the market share, owing to the presence of major players such as Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., etc., in the western European region.

Eastern Europe serves as a lucrative market opportunity for western giants to establish subsidiaries and retail outlets. Asia Pacific holds a 25% market share on account of the rising prevalence of chronic disease and huge government expenditures to execute research activities pertaining to drug discovery and development.

Periods of History and Forecast

This research report presents the analysis of each segment from 2017 to 2027, considering 2018 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market segmentation for the scope of the report is done by technology, end user, and geography.

Medical device-producing companies actively engaged in the manufacturing of life science instrumentation technology are Agilent Technologies, Inc., Bruker Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Merck KGaA, PerkinElmer, Inc., Shimadzu Corporation, Thermo Fisher Scientific, Inc., and Waters Corporation.

Key questions are answered in this report.

• What are the organic and inorganic growth strategies adopted by the life science instrumentation market?
• Which major players are competing in the life science instrumentation market?
• What are the latest technological advancements pertaining to different techniques used for drug sample quality control and validation?
• What will be the market performance of next-generation sequencing technology during the forecast period?
• What are the major applications of life science instrumentation techniques in pharmaceutical and biotechnology companies?
• Why is North America the dominant regional segment in the life science instrumentation market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global LSI Market Portraiture
2.2. Global LSI Market, by Technology, 2018 (US$ Mn)
2.3. Global LSI Market, by End User, 2018 (US$ Mn)
2.4. Global LSI Market, by Geography, 2018 (US$ Mn)

Chapter 3. Life Science Instrumentation (LSI) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global LSI Market, by Key Players, 2018

Chapter 4. Global Life Science Instrumentation (LSI) Market, by Technology
4.1. Overview
4.2. Spectroscopy
4.3. Chromatography
4.4. Polymerase Chain Reaction
4.5. Next Generation Sequencing
4.6. Clinical Chemistry Analyzers
4.7. Flow Cytometry
4.8. Immunoassays

Chapter 5. Global Life Science Instrumentation (LSI) Market, by End User
5.1. Overview
5.2. Research Institutes
5.3. Pharmaceutical and Biotechnology Companies
5.4. Diagnostic Laboratories

Chapter 6. Global Life Science Instrumentation (LSI) Market, by Geography
6.1. Overview
6.2. North America LSI Market Analysis, 2017 – 2027
6.2.1. North America LSI Market, by Technology, 2017 – 2027 (US$ Mn)
6.2.2. North America LSI Market, by End User, 2017 – 2027 (US$ Mn)
6.2.3. North America LSI Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe LSI Market Analysis, 2017 – 2027
6.3.1. Europe LSI Market, by Technology, 2017 – 2027 (US$ Mn)
6.3.2. Europe LSI Market, by End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific LSI Market Analysis, 2017 – 2027
6.4.1. Asia Pacific LSI Market, by Technology, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific LSI Market, by End User, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America LSI Market Analysis, 2017– 2027
6.5.1. Latin America LSI Market, by Technology, 2017 – 2027 (US$ Mn)
6.5.2. Latin America LSI Market, by End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa LSI Market Analysis, 2017 – 2027
6.6.1. MEA LSI Market, by Technology, 2017 – 2027 (US$ Mn)
6.6.2. MEA LSI Market, by End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Agilent Technologies, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bio-Rad Laboratories, Inc.
7.3. Bruker Corporation
7.4. Danaher Corporation
7.5. Illumina, Inc.
7.6. Merck KGaA
7.7. PerkinElmer, Inc.
7.8. Shimadzu Corporation
7.9. Thermo Fisher Scientific, Inc.
7.10. Waters Corporation

List of Figures

FIG. 1 Life Science Instrumentation (LSI) Market: Research Methodology
FIG. 2 LSI: Market Segmentation
FIG. 3 Global LSI Market, by Technology, 2018 (US$ Mn)
FIG. 4 Global LSI Market, by End User, 2018 (US$ Mn)
FIG. 5 Global LSI Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global LSI Market, by Key Players, 2018
FIG. 8 Global Spectroscopy Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 9 Global Chromatography Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 10 Global Polymerase Chain Reaction Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 11 Global Next Generation Sequencing Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 12 Global Clinical Chemistry Analyzers Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 13 Global Flow Cytometry Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 14 Global Immunoassays Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 15 Global Research Institutes Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 16 Global Pharmaceutical and Biotechnology Companies Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 17 Global Diagnostic Laboratories Market for LSI, 2017 – 2027 (US$ Mn)
FIG. 18 U.S. LSI Market, 2017 – 2027 (US$ Mn)
FIG. 19 Canada LSI Market, 2017 – 2027 (US$ Mn)
FIG. 20 U.K. LSI Market, 2017 – 2027 (US$ Mn)
FIG. 21 Germany LSI Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest of Europe LSI Market, 2017 – 2027 (US$ Mn)
FIG. 23 China LSI Market, 2017 – 2027 (US$ Mn)
FIG. 24 Japan LSI Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Asia Pacific LSI Market, 2017 – 2027 (US$ Mn)
FIG. 26 Brazil LSI Market, 2017 – 2027 (US$ Mn)
FIG. 27 Mexico LSI Market, 2017 – 2027 (US$ Mn)
FIG. 28 Rest of Latin America LSI Market, 2017 – 2027 (US$ Mn)
FIG. 29 GCC LSI Market, 2017 – 2027 (US$ Mn)
FIG. 30 Rest of MEA LSI Market, 2017 – 2027 (US$ Mn)

List of Tables

TABLE 1 Global Life Science Instrumentation (LSI) Market Portraiture
TABLE 2 Global LSI Market, by Technology, 2017 – 2027 (US$ Mn)
TABLE 3 Global LSI Market , by End User, 2017 – 2027 (US$ Mn)
TABLE 4 Global LSI Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America LSI Market, by Technology, 2017 – 2027 (US$ Mn)
TABLE 6 North America LSI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 7 North America LSI Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe LSI Market, by Technology, 2017 – 2027 (US$ Mn)
TABLE 9 Europe LSI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 10 Europe LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific LSI Market, by Technology, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific LSI Market, by End User, 2017 – 2027 US$ Mn)
TABLE 13 Asia Pacific LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America LSI Market, by Technology, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America LSI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa LSI Market, by Technology, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa LSI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa LSI Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bruker Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Illumina, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Merck KGaA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 PerkinElmer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Shimadzu Corporation.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Waters Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)